Monte Rosa Therapeutics Inc (GLUE)
6.91
+0.40
(+6.14%)
USD |
NASDAQ |
Dec 20, 16:00
6.915
0.00 (0.00%)
After-Hours: 20:00
Monte Rosa Therapeutics Profit Margin (Quarterly): -258.9% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Novartis AG | 24.21% |
| MEI Pharma Inc | -- |
| Evoke Pharma Inc | -49.45% |
| Revance Therapeutics Inc | -63.65% |
| Vera Therapeutics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Operating Margin (Quarterly) | -287.8% |